In addition, DANCR was known to promote progressions of bladder cancer cells by regulating the miR-149/MSI2 axis as a ceRNA (22), suggesting DANCR could be a therapeutic target against colon cancer. The gene discussed is DANCR; the disease is urinary bladder carcinoma.